| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/03/2011 | WO2011013639A1 Tablet |
| 02/03/2011 | WO2011013592A1 Coated preparation |
| 02/03/2011 | WO2011013546A1 Water-soluble polymer composition, composition for forming plaster layer of skin patch, and skin patch |
| 02/03/2011 | WO2011013138A1 Stable multi- vitamin formulations |
| 02/03/2011 | WO2011013130A2 Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof |
| 02/03/2011 | WO2011013110A1 Unit dosage forms of hiv protease inhibitors |
| 02/03/2011 | WO2011013082A1 Multi-layered, multiple unit pharmaceutical compositions |
| 02/03/2011 | WO2011013032A2 Method for the preparation of microparticles with efficient bioactive molecule incorporation |
| 02/03/2011 | WO2011013003A2 Intranasal granisetron and nasal applicator |
| 02/03/2011 | WO2011012912A2 New granulating process and thus prepared granulate |
| 02/03/2011 | WO2011012867A1 A delivery system comprising a silicon-containing material |
| 02/03/2011 | WO2011012866A1 Solutions comprising polyethylene glycol and electrolytes |
| 02/03/2011 | WO2011012774A1 Novel form of osteogenic protein administration |
| 02/03/2011 | WO2011012719A1 Long acting insulin composition |
| 02/03/2011 | WO2011012715A1 Biodegradable polyethylene glycol based water-insoluble hydrogels |
| 02/03/2011 | WO2011012369A2 Coating agent for the dip coating of capsule halves |
| 02/03/2011 | WO2011012335A1 Powdery or granulated composition comprising a copolymer, a salt of a fatty monocarboxylic acid and a fatty monocarboxylic acid and/or a fatty alcohol |
| 02/03/2011 | WO2011012312A1 Bladder instillation compositions for treating bladder cancer |
| 02/03/2011 | WO2011012217A2 Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof |
| 02/03/2011 | WO2011012163A1 Composition comprising an anionic polymeric material and the salt of a saturated monocarboxylic acid having 6 to 22 carbon atoms |
| 02/03/2011 | WO2011011978A1 Nanosphere or microsphere drug carrier, preparation method, composition and use thereof |
| 02/03/2011 | WO2011011905A1 A preparation process of blood fat and blood sugar lowering compound preparation |
| 02/03/2011 | WO2010144849A3 Dissolvable pharmaceutical implant |
| 02/03/2011 | WO2010140170A4 Topical micro-emulsions for the treatment of rheumatic disorders |
| 02/03/2011 | WO2010129445A3 Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound |
| 02/03/2011 | WO2010127159A3 Polymeric micelles for polynucleotide encapsulation |
| 02/03/2011 | WO2010115612A3 Pregabalin compositions |
| 02/03/2011 | WO2010111680A3 Dry powder formulations and methods for treating pulmonary diseases |
| 02/03/2011 | WO2010111215A3 Compositions and methods for treatment of hemorrhage |
| 02/03/2011 | WO2010111178A3 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
| 02/03/2011 | WO2010090611A3 Taste and odor masked pharmaceutical compositions with high bioavailability |
| 02/03/2011 | WO2010085589A3 Desensitizing drug product |
| 02/03/2011 | WO2010053597A3 Micelles of hydrophilically shielded membrane-destabilizing copolymers |
| 02/03/2011 | WO2010018003A3 Carrier system for biological agents containing organosilicon compounds and uses thereof |
| 02/03/2011 | WO2010003568A8 Topical composition for the treatment of actinic keratosis |
| 02/03/2011 | WO2009158412A8 Sustained delivery of exenatide and other polypeptides |
| 02/03/2011 | WO2009132050A9 Auris formulations for treating otic diseases and conditions |
| 02/03/2011 | WO2008006204A3 Fibrous calcium pyrophosphate particles and methods of making and using same |
| 02/03/2011 | US20110028901 Medication delivery system and monitor |
| 02/03/2011 | US20110028567 Smooth muscle contraction inhibitors |
| 02/03/2011 | US20110028555 Antiinflammatory and Analgesic Preparation for External Use |
| 02/03/2011 | US20110028535 Oligonucleotides-transferring preparations |
| 02/03/2011 | US20110028406 Pharmaceutical Compositions Comprising A Cyclosporin, A Hydrophilic Surfactant and a Lipophilic Surfactant |
| 02/03/2011 | US20110027883 Rna interference mediating small rna molecules |
| 02/03/2011 | US20110027455 Sequestering subunit and related compositions and methods |
| 02/03/2011 | US20110027379 Oligo-Ethylene Glycol-Based Polymer Compositions and Methods of Use |
| 02/03/2011 | US20110027378 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/03/2011 | US20110027377 Immediate release pharmaceutical granule compositions and a continuous process for making them |
| 02/03/2011 | US20110027376 Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds |
| 02/03/2011 | US20110027375 Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 02/03/2011 | US20110027374 Capecitabine rapidly disintegrating tablets |
| 02/03/2011 | US20110027373 Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathy |
| 02/03/2011 | US20110027372 Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release |
| 02/03/2011 | US20110027371 Nanoparticulate statin formulations and novel statin combinations |
| 02/03/2011 | US20110027370 Sustained Drug Release Composition |
| 02/03/2011 | US20110027369 Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients |
| 02/03/2011 | US20110027368 Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same |
| 02/03/2011 | US20110027367 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 02/03/2011 | US20110027366 Skin equivalent culture |
| 02/03/2011 | US20110027365 Patch Formulation For External Use |
| 02/03/2011 | US20110027364 Bioactive and resorbable soybean-based biomaterials |
| 02/03/2011 | US20110027362 Tablet having improved elution properties |
| 02/03/2011 | US20110027361 Extended release dosage form of paliperidone |
| 02/03/2011 | US20110027360 Pharmacokinetics of s-adenosylmethionine formulations |
| 02/03/2011 | US20110027359 Novel Pharmaceutical Compositions Comprising Levetiracetam |
| 02/03/2011 | US20110027358 Valsartan tablet formulations |
| 02/03/2011 | US20110027357 Compositions and methods for timed release of water-soluble nutritional supplements |
| 02/03/2011 | US20110027356 Combination of Oral Medicaments Bonded by a Wrapping |
| 02/03/2011 | US20110027355 High-fluidity and non-caking pulverulent crystalline maltitol composition |
| 02/03/2011 | US20110027354 Anti-parkinsonian compounds |
| 02/03/2011 | US20110027353 Therapeutic Delivery System |
| 02/03/2011 | US20110027352 Compounds for use in the treatment of neuropathic pain |
| 02/03/2011 | US20110027351 Liposomal formulations comprising an amphipathic weak base like tempamine for treatment of neurodegenerative conditions |
| 02/03/2011 | US20110027350 Glycopolysialylation of non-blood coagulation proteins |
| 02/03/2011 | US20110027349 Polypeptide vaccine and vaccination strategy against mycobacterium |
| 02/03/2011 | US20110027348 Composition and method inhibiting inflammation |
| 02/03/2011 | US20110027347 Polymersomes and methods of making and using thereof |
| 02/03/2011 | US20110027346 Lyase Enzymes, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 02/03/2011 | US20110027345 Composition containing rotigotine and use thereof and transdermal patch containing the composition |
| 02/03/2011 | US20110027344 Alginate-Containing Wound Dressing, Method and Apparatus for Making the Same |
| 02/03/2011 | US20110027342 S-adenosylmethionine formulations with enhanced bioavailability |
| 02/03/2011 | US20110027340 Implantable drug depot for weight control |
| 02/03/2011 | US20110027338 Biologic replacement for fibrin clot |
| 02/03/2011 | US20110027335 Coated medical devices |
| 02/03/2011 | US20110027331 An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation |
| 02/03/2011 | US20110027329 Single-use, Disposable Strip For Application Of Topical Compositions |
| 02/03/2011 | US20110027327 Cosmetic or pharmaceutical composition for topical application |
| 02/03/2011 | US20110027326 External Composition for Skin |
| 02/03/2011 | US20110027325 Orally-administered agent |
| 02/03/2011 | US20110027324 O-desmethyl-venlafaxine for treating major depressive disorder |
| 02/03/2011 | US20110027272 Stabilized liquid anti-rsv antibody formulations |
| 02/03/2011 | US20110027204 title compound is adapalene; acne gel or cream |
| 02/03/2011 | US20110027193 Compositions and methods for the treatment of inflammatory conditions |
| 02/03/2011 | US20110027188 Methods, Compositions and Devices for Treating Lesioned Sites Using Bioabsorbable Carriers |
| 02/03/2011 | US20110027181 Device including altered microorganisms, and methods and systems of use |
| 02/03/2011 | US20110027174 Nanotubes for cancer therapy and diagnostics |
| 02/03/2011 | US20110027172 Drug delivery system for pharmaceuticals and radiation |
| 02/03/2011 | US20110027171 Ph sensitive liposome composition |
| 02/03/2011 | US20110024929 Apparatus for producing liposomes and method of producing liposomes |
| 02/03/2011 | US20110023876 Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems |